Charles Schwab’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,239,555
| Closed | -$5.08M | – | 3719 |
|
|
2022
Q1 | $5.08M | Buy |
1,239,555
+45,805
| +4% | +$188K | ﹤0.01% | 2272 |
|
|
2021
Q4 | $4.26M | Buy |
1,193,750
+32,378
| +3% | +$116K | ﹤0.01% | 2429 |
|
|
2021
Q3 | $4.23M | Buy |
1,161,372
+53,498
| +5% | +$195K | ﹤0.01% | 2453 |
|
|
2021
Q2 | $4.83M | Buy |
1,107,874
+17,435
| +2% | +$76K | ﹤0.01% | 2370 |
|
|
2021
Q1 | $4.48M | Buy |
1,090,439
+62,183
| +6% | +$256K | ﹤0.01% | 2350 |
|
|
2020
Q4 | $4.1M | Buy |
1,028,256
+3,276
| +0.3% | +$13.1K | ﹤0.01% | 2314 |
|
|
2020
Q3 | $2.77M | Sell |
1,024,980
-34,910
| -3% | -$94.3K | ﹤0.01% | 2374 |
|
|
2020
Q2 | $2.92M | Buy |
1,059,890
+93,426
| +10% | +$257K | ﹤0.01% | 2282 |
|
|
2020
Q1 | $2.28M | Buy |
966,464
+18,360
| +2% | +$43.3K | ﹤0.01% | 2223 |
|
|
2019
Q4 | $4.46M | Buy |
948,104
+1,926
| +0.2% | +$9.05K | ﹤0.01% | 2078 |
|
|
2019
Q3 | $3.17M | Buy |
946,178
+21,024
| +2% | +$70.3K | ﹤0.01% | 2203 |
|
|
2019
Q2 | $3.04M | Buy |
925,154
+68,438
| +8% | +$225K | ﹤0.01% | 2200 |
|
|
2019
Q1 | $2.6M | Buy |
856,716
+36,191
| +4% | +$110K | ﹤0.01% | 2273 |
|
|
2018
Q4 | $2.23M | Sell |
820,525
-8,261
| -1% | -$22.5K | ﹤0.01% | 2295 |
|
|
2018
Q3 | $2.79M | Buy |
828,786
+84,598
| +11% | +$284K | ﹤0.01% | 2318 |
|
|
2018
Q2 | $1.92M | Buy |
744,188
+32,626
| +5% | +$84.2K | ﹤0.01% | 2391 |
|
|
2018
Q1 | $1.57M | Buy |
711,562
+104,733
| +17% | +$230K | ﹤0.01% | 2403 |
|
|
2017
Q4 | $1.21M | Buy |
606,829
+45,893
| +8% | +$91.4K | ﹤0.01% | 2458 |
|
|
2017
Q3 | $1.82M | Buy |
560,936
+27,360
| +5% | +$88.7K | ﹤0.01% | 2325 |
|
|
2017
Q2 | $1.72M | Buy |
533,576
+244,483
| +85% | +$788K | ﹤0.01% | 2269 |
|
|
2017
Q1 | $822K | Buy |
289,093
+26,847
| +10% | +$76.3K | ﹤0.01% | 2488 |
|
|
2016
Q4 | $612K | Buy |
262,246
+24,178
| +10% | +$56.4K | ﹤0.01% | 2586 |
|
|
2016
Q3 | $400K | Buy |
238,068
+20,470
| +9% | +$34.4K | ﹤0.01% | 2697 |
|
|
2016
Q2 | $229K | Sell |
217,598
-249,999
| -53% | -$263K | ﹤0.01% | 2883 |
|
|
2016
Q1 | $407K | Buy |
467,597
+7,650
| +2% | +$6.66K | ﹤0.01% | 2657 |
|
|
2015
Q4 | $557K | Buy |
459,947
+9,750
| +2% | +$11.8K | ﹤0.01% | 2607 |
|
|
2015
Q3 | $766K | Buy |
450,197
+25,635
| +6% | +$43.6K | ﹤0.01% | 2468 |
|
|
2015
Q2 | $884K | Buy |
424,562
+106,669
| +34% | +$222K | ﹤0.01% | 2467 |
|
|
2015
Q1 | $862K | Buy |
317,893
+15,660
| +5% | +$42.5K | ﹤0.01% | 2424 |
|
|
2014
Q4 | $777K | Buy |
302,233
+42,171
| +16% | +$108K | ﹤0.01% | 2457 |
|
|
2014
Q3 | $476K | Buy |
260,062
+4,417
| +2% | +$8.09K | ﹤0.01% | 2609 |
|
|
2014
Q2 | $683K | Sell |
255,645
-34,529
| -12% | -$92.3K | ﹤0.01% | 2502 |
|
|
2014
Q1 | $1.02M | Buy |
290,174
+36,355
| +14% | +$127K | ﹤0.01% | 2281 |
|
|
2013
Q4 | $1.14M | Sell |
253,819
-13,435
| -5% | -$60.2K | ﹤0.01% | 2207 |
|
|
2013
Q3 | $1.17M | Buy |
267,254
+3,445
| +1% | +$15K | ﹤0.01% | 2145 |
|
|
2013
Q2 | $1.12M | Buy |
+263,809
| New | +$1.12M | ﹤0.01% | 2098 |
|